Landry Robert E Insider Trades

Insider Trading History

Track insider trading activity for Landry Robert E. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cytokinetics
Cytokinetics CYTK
Director
Holding Value $539k 8,184 shares
Last Trade
Sep 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$72.1k 1,000 shares
$72.13
$65.91
Cytokinetics
Cytokinetics CYTK
Director
Holding Value $605k 9,184 shares
Last Trade
Sep 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$74.7k 1,000 shares
$74.66
$65.91
Cytokinetics
Cytokinetics CYTK
Director
Holding Value $671k 10,184 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$552k 7,152 shares
$77.15
$65.91
Zymeworks BC
Zymeworks BC ZYME
Director
Holding Value $305k 11,500 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 19,200 shares
$23.16
$26.49
Zymeworks BC
Zymeworks BC ZYME
Director
Holding Value $1.64M 62,000 shares
Last Trade
Aug 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$771k 62,000 shares
$12.44
$26.49
Cytokinetics
Cytokinetics CYTK
Director
Holding Value $717k 10,880 shares
Last Trade
May 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$326k 10,880 shares
$30.00
$65.91
Cytokinetics
Cytokinetics CYTK
Director
Holding Value $1.68M 25,538 shares
Last Trade
Feb 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 25,538 shares
$42.21
$65.91
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $18.2M 23,974 shares
Last Trade
Feb 02, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$378k 400 shares
$945.18
$758.27
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $18M 23,693 shares
Last Trade
Feb 02, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$269k 281 shares
$956.65
$758.27
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $8.94M 11,787 shares
Last Trade
Feb 02, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$378k 400 shares
$945.18
$758.27
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $9.24M 12,187 shares
Last Trade
Jan 31, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$377k 400 shares
$942.78
$758.27
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $18.1M 23,856 shares
Last Trade
Jan 31, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$377k 400 shares
$942.78
$758.27
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $17.9M 23,574 shares
Last Trade
Jan 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$269k 282 shares
$953.42
$758.27
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $18.1M 23,808 shares
Last Trade
Jan 24, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$474k 500 shares
$948.24
$758.27
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $9.54M 12,587 shares
Last Trade
Jan 24, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$474k 500 shares
$948.24
$758.27
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $17.8M 23,456 shares
Last Trade
Jan 24, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$335k 352 shares
$951.26
$758.27
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $18.3M 24,084 shares
Last Trade
Jan 23, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.05M 1,100 shares
$954.58
$758.27
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $9.92M 13,087 shares
Last Trade
Jan 23, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.05M 1,100 shares
$954.58
$758.27
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $17.7M 23,308 shares
Last Trade
Jan 23, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$736k 776 shares
$948.50
$758.27
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Finance CFO
Holding Value $17.4M 22,984 shares
Last Trade
Jan 17, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$330k 354 shares
$932.34
$758.27

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up